Kalowski Lee Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
17
Insider Sells Sum
$3.58M

Insider Activity of Kalowski Lee

According to the SEC Form 4 filings, Kalowski Lee, being in a position of

  1. CFO and President at Q32 Bio Inc.,
    оver the last 12 months, has bought 0 shares, and sold 18340 shares for $126,031,
    over all time since 2025-08-26, has bought 0 shares, and sold 22580 shares for $133,667.

Biography of Kalowski Lee

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
$000
Sells
$126,0314100

Comparison of Insiders on Amount of Buys and Sells

2026-10-06SaleQ32 Bio Inc.
QTTB
CFO and President
1,301
0.0045%
$8.32$10,824+6.47%
2026-08-25SaleQ32 Bio Inc.
QTTB
CFO and President
3,972
0.0135%
$16.56$65,776-45.4%
2026-02-25SaleQ32 Bio Inc.
QTTB
CFO and President
3,995
0.031%
$4.51$18,035+89.96%
2025-12-02SaleQ32 Bio Inc.
QTTB
CFO and President
9,072
0.0762%
$3.46$31,395+109.38%
2025-08-26SaleQ32 Bio Inc.
QTTB
CFO and President
4,240
0.0185%
$1.80$7,636+157.69%
2023-04-03SaleBicycle Therapeutics plc
BCYC
President and CFO
376
0.0012%
$21.11$7,937-0.23%
2023-01-03SaleBicycle Therapeutics plc
BCYC
President and CFO
1,815
0.0059%
$29.06$52,744-27.23%
2021-09-02SaleBicycle Therapeutics plc
BCYC
President and CFO
10,000
0.0392%
$40.00$400,000+4.26%
2021-08-27SaleBicycle Therapeutics plc
BCYC
President and CFO
7,950
0.0336%
$35.15$279,443+27.98%
2021-08-26SaleBicycle Therapeutics plc
BCYC
President and CFO
550
0.0023%
$35.04$19,272+26.89%
2021-08-23SaleBicycle Therapeutics plc
BCYC
President and CFO
7,500
0.0298%
$33.02$247,650+27.85%
2021-07-29SaleBicycle Therapeutics plc
BCYC
President and CFO
12,500
0.0504%
$31.51$393,823+36.09%
2021-01-19SaleBicycle Therapeutics plc
BCYC
President and CFO
30,000
0.0716%
$15.79$473,850+4.84%
2021-01-14SaleBicycle Therapeutics plc
BCYC
President and CFO
20,000
0.0472%
$13.30$266,000+22.75%
2020-12-01SaleBicycle Therapeutics plc
BCYC
President and CFO
15,000
0.0463%
$12.03$180,450+47.89%
2020-11-27SaleBicycle Therapeutics plc
BCYC
President and CFO
1,060
0.0029%
$10.78$11,427+47.16%
2020-11-25SaleBicycle Therapeutics plc
BCYC
President and CFO
19,562
0.1036%
$20.07$392,609+51.77%
2020-11-23SaleBicycle Therapeutics plc
BCYC
President and CFO
34,378
0.1788%
$19.83$681,611+50.68%
2015-09-08SaleEledon Pharmaceuticals, Inc.
ELDN
Chief Financial Officer
4,668
0.0209%
$13.13$61,291-47.42%
2015-09-02SaleEledon Pharmaceuticals, Inc.
ELDN
Chief Financial Officer
2,158
0.0094%
$12.96$27,968-48.19%
Total: 22
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.